Vitori Voice

Categories | Subscribe | Popular

How NOT to Boost Employee Satisfaction with Your Health Plan

2 min

A new study shows that 71% of US employers expect moderate to significant increases in healthcare costs over the next three years, including a 6% rise in 2023. While the need to manage costs is clear, it’s shocking that 1-in-4 employers plans to shift costs to employees through higher contributions.

As quoted in the WTW study, “Employers must focus on changes that go beyond addressing their employees’ needs to also support efforts to attract and retain talent during a tight labor market.”

Increasing premium contributions effectively reduces employee income and quality of life, and is contrary to a growing focus on making employee benefits more affordable. It’s certainly not the best way to win the war for talent and boost employee satisfaction and retention.

In addition to higher payroll deductions, 23% of employers surveyed have further eroded employee earnings and freedom of choice by increasing out-of-pocket costs for non-preferred labs, providers, and facilities. Another 19% expect to do so by 2024. Boxing employees into narrow networks is never popular and does little to effectively balance cost management with health care affordability.

Doing the Right Thing for Employees

Employers have a fiduciary responsibility under ERISA to manage plan expenses on behalf of plan participants. At the same time, they need to seek competitive advantages and avoid future risk. A next-generation health plan is a strategic tool for meeting these goals by countering inflationary pressures and making health care affordable without reducing benefits.

While 27% of respondents currently use programs to combat fraud and waste, such capabilities can be fully integrated into a modern health plan to ensure sustainable savings and help prevent such abuse from happening in the first place.

The same is true for concierge support services, which help employees navigate the healthcare system and get more value from their health plan. A key driver of employee satisfaction, this essential service is currently only offered by 21% of respondents, with another 25% expecting to do so by 2024.

Employers willing to let go of their “devil you know” mindset can deliver better, more affordable health care for their employees and successfully fight the rising costs and low transparency of legacy health plans.

More Patients and Providers Value Telehealth for Mental Health Care

2 min

According to the National Institutes of Health, telehealth services have been around since the 1920s using the limited technologies of their time. A century later, virtual care has become commonplace thanks to the global pandemic… and it is here to stay, especially for mental health services.

A study published by the Centers for Disease Control and Prevention shows that in the first three months of 2020, telehealth usage grew 154% over the same period in 2019. While much of the initial surge was related to COVID-19 (contagion, social distancing, staffing shortages, etc.), 93% of telehealth patients sought care for conditions other than COVID-19 during the 2020 study period.

Clearly patients appreciate the convenience and benefits of telehealth for a multitude of services. What about practitioners? How do they perceive the value of telehealth as a way to deliver care?

The Journal of the American Medical Association surveyed mental health, primary care, and specialty care providers to learn more about their experience. Questions covered telehealth quality and ease of use as well as the proportion of care delivered via phone, video, and in-person visits.

At the time of the survey, mental health practitioners had significantly more telehealth encounters (40.3%) than other types of providers, likely because “telehealth was being used for MH (mental health) care well before the onset of the COVID-19 pandemic.”

Survey results show that mental health practitioners:

  • Prefer video visits over phone visits for remote care by as much as 86.4%
  • Rate the quality of video visits as equivalent to (up to 50.1%) or better than (up to 41.7%) in-patient visits for both new and established patients
  • Report fewer challenges to delivering phone and video care (5.6%—26%) compared to primary care (7.6%—9%%) and specialty care (13.7%—63.8%) providers

While efforts are being made to reduce barriers to telehealth in general, employers can take action now by including coverage for free remote behavioral health services in their employee health plan, thus removing a financial barrier to seeking this important care and improving employee satisfaction.

Who Do You Think Pays Better Rx Prices? Pets or People?

2 min

Saying things have “gone to the dogs” implies a worsened situation. However, a recent study by the Journal of the American Medical Association (JAMA) shows that dogs have a leg up and humans get the short end of the stick, paying more for commonly prescribed drugs used to treat both people and pets.

JAMA’s cross-sectional study compared 120 of the 200 most-prescribed generic human medications with unique active ingredients to the corresponding pet formulations to derive the human-to-pet price ratio. The average retail price (ARP) for humans was determined using GoodRx, with discounted prices obtained from Costco pharmacy. Pet prices were determined using online pet pharmacies such as Chewy.

The human ARP was a staggering 93.3% higher than the pet price; discounted prices were 64.2% higher. Researchers “found that prices of most medications were higher for humans than for pets. Even discounted prices for humans, a best-case scenario of out-of-pocket costs for patients without prescription drug coverage, were higher than pet prices for two-thirds of medications.”

Some results were even more significant. Check out the full study for citations relative to these results as well as several informative infographics.

  • Phytonadione
    Oral vitamin K1
    Human | 5mg tablet | $70.51
    Veterinary | 50mg tablet | $0.61.4 (61.4¢)
  • Levamisole
    Introduced in the 1960s as a veterinary anti-parasitic medication. When determined to be efficacious in treating human colon cancer, the human brand-name version (Janssen’s Ergamisol) was introduced.
    Human | 50mg tablet | $5
    Veterinary | 50mg tablet | $0.05 (5¢)

The researchers acknowledge that medication prices are dynamic and that there are “opaque rebates underlying discounted prices.” As a result, human prices are often not proportional to drug strength or fill quantity.

We concur with JAMA’s conclusion that “cash prices for generic medications should be transparent and accessible to people, for their own use and for their pets.” Paws up if you agree!

Patients Pushed to Use Medical Credit Cards to Pay for Needed Care

3 min

Technology leaders and top executives from US hospitals and health systems met recently to focus on healthcare affordability and transforming the patient financial experience. Although many good ideas were generated, the definition and expectation of affordability clearly varies by stakeholder.

Participants in the leadership summit acknowledged that “healthcare in the U.S. is notoriously expensive, including for many people covered by insurance — a reality underscored by the role medical debt plays in more than 60 percent of bankruptcies.” Yet for these constituents, affordability means “enlightened” payment plans that “focus on maximizing the repayment success of the patient.” In other words, let’s improve the odds of the patient paying a bill that is outrageously and unnecessarily high.

The Rapid Rise of Medical Credit Cards

The healthcare industry is increasing its use of technology to improve what it calls the “patient financial experience.” Direct-to-provider payment plans are still the norm, but they are rapidly being replaced by medical credit cards whose lines of credit roughly equal the amount of the patient’s bill.

Research for an article in Crain’s Chicago Business revealed that Synchrony Financial, one of the largest issuers of medical credit cards, reported a 50% increase in purchase volume (from $8 to nearly $12 billion) from 2015 to 2021. The author predicts that it’s just a matter of time before medical credit cards overtake payment plans as the preferred financing method. But preferred by whom?

Hospitals love them because they get paid up front and incur lower transaction fees: a single swipe for a one-time payment vs. 60 swipes for a five-year payment plan. These cards are also promoted (with training provided by the card issuers) by dentists, cosmetic surgeons, and providers whose charges are out of pocket or subject to high deductibles. Even veterinarians are in on the game.

So while hospitals and providers clear outstanding charges from their books, their alliance with medical credit card companies pushes patients into a debt vehicle that’s not in their best interest. The ethics get murkier for nonprofit hospitals who should be providing acceptable levels of free care and services to the community in exchange for substantial tax relief.

Do Patients Benefit from Medical Credit Cards?

Patient reaction to medical credit cards is decidedly mixed. While some appreciate the convenience, others feel they were preyed upon or misled about the terms of their debt, specifically the no-interest introductory period and when interest charges begin accruing. Patients report being pushed to open an account during point of care, including in the emergency room or at discharge.

Kristen Schell, who was profiled in the Crain’s article, says she was pressured into charging urgent gall bladder surgery to a medical credit card, despite being in the financial field for 15 years and “knowing better” that it was not prudent.

Consumer credit experts say medical credit cards should be the last resort for paying a large medical bill. Interest rates are higher: CareCredit is close to 27% while regular credit cards average 19% to 20%. And once medical debt hits a credit card of any kind, it is indistinguishable from consumer debt.

This is a very important consideration for anyone supposedly concerned about the patient financial experience. Consumers rejoiced when the three major credit reporting agencies agreed to remove medical debt from credit reports. However, this only applies to money owed directly to a hospital, care provider, or collection agency. It does not apply to medical debt on any type of credit card. Once charged, it’s just a massive amount of debt in the patient’s credit history that’s viewed less favorably by credit card bureaus.

Transparency and True Affordability

The most encouraging outcome of the leadership summit was a push toward price transparency. Participants acknowledged that “patients still have surprisingly little visibility into what they owe, why they owe it, and how they can pay for it in a way that fits within their budgets.” Additionally, patients “rarely have an opportunity to inform themselves what a consultation, a lab test or an intervention will cost them.”

Technology and artificial intelligence chat bots are being touted as mechanisms to digitize and improve the patient financial experience. And while the technology may be ready, the industry is not. An executive from a Chicago-based health system made the following observation.

“Organizations are putting their prices out there and patients are looking at quality and at what it might cost them, but the problem is they don’t understand the full cost because there’s all this back work with payers about what their true out-of-pocket will be.” In reality, better payment predictive analytics are needed for these efforts to have any real value to consumers.

From a patient perspective, knowing real and accurate costs in advance doesn’t necessarily make them reasonable or affordable, but such transparency is a step in the right direction in that it supports better financial decision making when it comes to health care.

Helping Employees Navigate the System

Employers should consider these two highly effective ways to help protect the financial and health interests of their employees.

  • Improve financial literacy through direct education and a compassionate, member-focused health plan that unburdens plan administrators by offering unlimited access to personalized support services during open enrollment and beyond.
  • Implement a next-generation employee health plan designed around accountability, transparency, cost-containment and guaranteed savings that prioritizes employer and member needs over those of the healthcare industry.

Insurer Profits Are Strong While Patients Struggle to Pay Bills

< 1 minute

While patients grapple with runaway costs and the indignities of the U.S. healthcare system, the largest health insurance firms posted solid year-over-year earnings growth for the first half of 2022. In fact, experts don’t think they’ll struggle at all despite worrisome economic conditions.

These same experts also believe insurers with diverse revenue streams will stay strong as they absorb the impacts of lower enrollment as a result of inflation; rising medical costs; a possible recession, which could reduce employer-based enrollment; and the resumption of Medicaid eligibility redeterminations.

Why the disparity between insurers and the insured?

The answer is two-fold, according to Ge Bai, Ph.D., a professor at Professor at Johns Hopkins Carey Business School and Johns Hopkins Bloomberg School of Public Health.

In an interview with AIS Health, Bai points out that “insurance companies, because of their market position, are able to pass on inflation impacts to their end consumers.” Plan sponsors and ultimately, their members, bear the brunt of higher costs while insurers pocket greater profits.

Bai also articulates what many hesitate to say… that insurance companies “have pretty much captured customers. It’s not a very competitive market.” With little competition and no incentive to change current business practices, the greed and inequity will surely continue.

Employers and plan sponsors cannot rely on monopoly legacy insurance companies to care about their best interests. They need to take a more progressive approach and find an employee health plan that does care, especially with today’s rising inflation and the possibility of recession.

Unethical and Illegal: Cancer Centers Are Still Hiding Drug Prices

2 min

Consumers cheered when the Hospital Price Transparency rule took effect in January 2021, requiring that facilities publish their payer-specific negotiated rates for drugs and services. Despite the positive news, there remains a blatant lack of compliance that continues to keep patients in the dark.

Everyone deserves a less costly, more compassionate health plan, especially those being treated for cancer. To follow up on how well the new rule was driving transparency, JAMA Internal Medicine conducted a study of private-payer prices for 25 commonly used cancer therapies at 61 cancer treatment centers so designated by the National Cancer Institute.

In its review of the JAMA study, Cancer Therapy Advisor summarizes the results by saying, “A majority of National Cancer Institute (NCI)-designated cancer centers violated federal law last year by failing to disclose payer-specific prices for cancer therapies.” By year-end, only 44% had disclosed private-payer prices for at least 1 of the 25 top-selling therapies. The remaining 56% remained utterly opaque and in defiance of the rule.

The JAMA study further estimated the acquisition costs for each of the 25 therapies and the extent to which they were marked up by the hospitals administering them. Median markups across all centers and payers ranged between 118% to a whopping 634%. Negotiated prices also varied considerably between payers at the same center.

JAMA concludes by stating, “The findings of this cross-sectional study suggest that, to reduce the financial burden of cancer treatment for patients, institution of public policies to discourage or prevent excessive hospital price markups on parenteral chemotherapeutics might be beneficial.”

It’s important to ensure that employer health plan sponsors pay fair prices not only for medical services and retail pharmacy drugs, but also for all drug claims on the medical plan, like those used for cancer treatment.

Advisors and employer health plan sponsors are best served by health plan administrators like Vitori Health that incorporate reimbursement controls for drugs delivered in facility care settings. This can have a significant impact in reducing overspending for employers and patients going through difficult life and death treatments.

Employers Need a Better Formulary to Deliver Rx Value and Savings

2 min

Americans spend about $500 billion a year on prescription drugs with no visibility into the processes that set prices or the comparative effectiveness of drugs approved for the same clinical purpose. This opaqueness makes it impossible to ensure that prices are aligned with the value a drug provides.

PBMs are primarily responsible for this lack of transparency by adding cost through spread pricing and creating drug formularies based on the rebates they receive from manufacturers. The good news for employer health plan sponsors and their members is that some researchers are trying to change this.

In their review of research by the Center for Evaluation of Value and Risk in Health at Tufts Medical Center, Health Affairs notes that there is no single entity in the U.S. that makes drug coverage and pricing decisions. This is compounded by the mix of private and public payers that follow different rules, and a system that grants monopolies to drug manufacturers and allows them to charge whatever the market will bear.

A Way Forward

The way out of this mess is to build prescription drug formularies that consider comparative effectiveness research and cost. The researchers support the science-driven approach that is advocated by the Institute for Clinical and Economic Review (ICER) and is used by next-generation Rx plans to deliver better value and better outcomes.

ICER is an independent, non-profit research organization founded in 2006 at Harvard Medical School. It evaluates the clinical and economic value of prescription drugs, medical tests and devices, and health system delivery innovations. ICER believes that when drug pricing reflects how well the drug improves patients’ lives, it will incentivize transformational innovation by rewarding pharmaceutical companies for developing more highly effective drugs. Without such philosophical and economic shifts, Americans will continue to pay too much for drugs that do too little.

ICER has developed a recommended health-benefit price benchmark (HBPB) for U.S. drug prices, net of rebates and discounts. This is certainly a step in the right direction but as we know, rebates and other PBM practices are little more than a scam. Additionally, of all the drugs ICER has assessed, only slightly more than 25% were priced within their HBPB range.

Brokers and advisors can empower employers by offering prescription drug plans that deliver value based on cost and comparative clinical efficacy. It’s time to replace the predatory practices and overriding profit motive of PBMs with formularies that prioritize drugs offering the best overall value based on comparative data, next-generation payment technology, smart sourcing, and evidence-based improvements in patient outcomes and savings.

Contact Vitori Health for information about our non-PBM VitoriRx plan that does all this and more.

Join Us for Exciting Insights at the Health Rosetta Summit

2 min

Health Rosetta Summit 2022 Denver Vitori Health Sponsorship

The Health Rosetta is an innovative blueprint for high performance health plans that is transforming the benefits experience for employers and plan members. Vitori Health supports this mission and is proud to sponsor and attend the upcoming Health Rosetta Summit in Denver.

Our shared mission can be summarized as simplifying the path to lower costs and improved financial performance through better benefits, improved outcomes, and higher quality care for employees. The Health Rosetta framework contains these foundational components and is constantly evolving to include more and better components, case studies, data, best practices, and related solutions.

Gathering to Do Good

The Health Rosetta Summit will take place on August 15-17, 2022 in Denver, Colorado. The outstanding speakers and robust content will focus on how “Transparency Rebuilds the American Dream” and is a proven path to delivering world class health care to employees at significantly less cost.

The goal is for attendees to collaborate with the CEOs, union and civic leaders, and benefits advisors who have “transformed health plans from the #1 driver of inflation, poverty and bankruptcy to the top driver of restoring hope and well-being.”

Vitori Health is proud to sponsor and participate in this exceptional event. Attendees visiting the Hydration Station can pick up an eco-friendly water bottle and enjoy a variety of beverages to stay healthy and hydrated throughout the summit.

We are also hosting a raffle at the Hydration Station for an inflatable stand-up paddleboard. Just scan the QR code and use our Dynamic Financial Impact Calculator to estimate savings using Vitori Health. Downloading the results automatically enters attendees in the raffle.

We look forward to strengthening our connections to member advisors, employers, solutions providers, and ecosystem guests at this Health Rosetta community-building event. It’s time to scale simple, practical, and proven fixes to the healthcare system!

Better Health Insurance Literacy Can Reduce High Health Care Costs

2 min

Employers take great care to choose the best possible health plan for their members. But to get value from their plan, employees must understand common health insurance terms to make sound health care decisions. A recent study shows how a lack of literacy is resulting in confusion and higher costs.

The 2022 health insurance literacy survey published by HealthCare.com asked respondents how well they understood specific health insurance language. The results show “bewilderment over a wide range of health insurance terms and how health insurance functions in the United States.”

Health Insurance Literacy 1
Source: Health Insurance Literacy Survey 2022

Despite these varying degrees of confidence, it’s clear that respondents don’t correctly understand how things work.

For example, “copay” ranks as the best understood of all the health insurance terms presented. And yet half of all respondents erroneously “believe that copays count toward deductibles when they generally do not.”

Health Insurance Literacy 2
Source: Health Insurance Literacy Survey 2022

Additionally, “understanding the meaning of “in-network is crucial to not getting socked by unexpected health insurance bills. But 4 in 10 respondents (41%) were unable to select the correct option” among four choices to describe its meaning: “See only doctors who are contracted with a carrier associated with your policy.”

As a result, “1 in 4 Americans (26%) say lack of health insurance understanding caused them to receive a higher than expected medical bill.”

Strategies for Empowerment

Employers are ideally positioned to bring clarity to the healthcare conversation and help employees avoid surprise medical bills due to misunderstandings. Here are several strategies that can help members (and employers) in significant ways.

  • Expand current financial education programs to include health insurance education. Human Resources and/or plan administrators can create custom resources that meet the specific needs of their workforce and reinforce this information during open enrollment.
  • Implement a compassionate, member-focused health plan that unburdens plan administrators by offering unlimited access to personalized support services during open enrollment and beyond. Services should combine member assistance with claims, unexpected bills, and providers, with education on plan features and guidance navigating the healthcare system.
  • Choose an open access plan that eliminates confusion about network providers and the potential for high or unexpected medical bills.
  • Avoid legacy insurance carrier plans that have strict networks as well as reference-based pricing (RBP) plans, which are adversarial with providers. Payment under RBP plans is considered unfair, and providers often bill patients for the balance of what they thought they should have been paid. Instead, consider a next-generation plan that uses Fair Market Payment™ (FMP) that is equitable for providers, employers, and plan members while saving significantly over legacy insurance plans.

Everyone benefits when employees understand health insurance language and have a simpler, cost-saving, open access plan with better member support.

$2,885 Average Savings Per Employee with NO Cost Shifting | Estimate Your Savings

X